Publikationen im NUM

Hier finden Sie eine Liste der Publikationen, die im Zusammenhang mit dem Netzwerk Universitätsmedizin in der ersten und zweiten Förderphase entstanden sind.

A. Schuppert, K. Polotzek, J. Schmitt, R. Busse, J. Karschau and C. Karagiannidis, "Different spreading dynamics throughout Germany during the second wave of the COVID-19 pandemic: A time series study based on national surveillance data", The Lancet Regional Health - Europe, vol. 6, pp. 100151, 2021.
DOI:10.1016/j.lanepe.2021.100151
Datei:https://doi.org/10.1016/j.lanepe.2021.100151
R. J. Neumann, B. Kollmann, M. M. Plichta, K. Lieb, O. Tüscher and A. Reif, "Differential impact of COVID-related lockdown on mental health in Germany", World Psychiatry, vol. 20, no. 1, pp. 140—141, 2021.
DOI:10.1002/wps.20830
K. Vanshylla and et al, "Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers", Cell host & microbe, 2021.
DOI:10.1016/j.chom.2021.12.010
S. Schlickeiser, T. Schwarz, S. Steiner, K. Wittke, O. Meyer, U. Kalus, A. Pruß, F. Kurth, T. Zoller and D. Stahl, "Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses", Front Immunol, vol. 11, pp. 628971, 2021.
DOI:10.3389/fimmu.2020.628971
F. Heinrich, C. Romich, T. Zimmermann, I. Kniep, A. Fitzek, S. Steurer, M. Glatzel, D. Nörz, T. Günther, M. Czech-Sioli, N. Fischer, A. Grundhoff, M. Lütgehetmann and B. Ondruschka, "Dying of VOC-202012/01 - multimodal investigations in a death case of the SARS-CoV-2 variant", Int J Legal Med, pp. 1-10, 2021.
DOI:10.1007/s00414-021-02618-8
S. Deinhardt-Emmer, D. Wittschieber, J. Sanft, S. Kleemann, S. Elschner and e. a. Haupt, "Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage", Elife, vol. 10, 2021.
L. Gieselmann and et al, "Effective high-throughput isolation of fully human antibodies targeting infectious pathogens", Nature Protocols, 2021.
DOI:10.1038/s41596-021-00554-w
A. Deckert and D. Stahl, "Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial", Trials, vol. 22, no. 1, 2021.
DOI:10.1186/s13063-020-04982-z
Datei:https://doi.org/10.1186/s13063-020-04982-z
A. Deckert and et al, "Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial", Trials, vol. 22, no. 1, 2021.
DOI:10.1186/s13063-020-04982-z
A. Deckert and D. Stahl, "Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): study protocol for a two-factorial randomized controlled multi-arm trial with cluster sampling", Trials, vol. 22, no. 1, 2021.
DOI:10.1186/s13063-021-05619-5
Datei:https://doi.org/10.1186/s13063-021-05619-5
A. Deckert, M. De Allegri and et al, "Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): study protocol for a two-factorial randomized controlled multi-arm trial with cluster sampling", Trials, vol. 22, no. 1, 2021.
DOI:10.1186/s13063-021-05619-5
P. Beschoner, M. Jarczok, M. Kempf, K. Weimer, F. Geiser, N. Hiebel, Y. Erim, E. Morawa, S. Steudte-Schmiedgen and L. Jerg-Bretzke, "egePan-VOICE study on the psychosocial burden of the Covid-19 pandemic among medical technical assistants", Z Psychosom Med Psychother, 2021.
S. Zellmer, M. Kahn, A. Ebigbo and et al, "Ein Jahr Covid-19: Testung, Verwendung von Schutzausrüstung und Auswirkungen auf die Gastrointestinale Endoskopie in Deutschland", Z Gastroenterol, vol. 59, no. 8, 2021.
DOI:10.1055/s-0041-1734140
M. Kahn, S. Zellmer, A. Ebigbo and et al, "Ein Jahr Covid-19: Testung, Verwendung von Schutzausrüstung und Auswirkungen auf die Gastrointestinale Endoskopie in Deutschland", Z Gastroenterol, vol. 59, no. 12, 2021.
DOI:10.1055/a-1649-8184
B. Jensen, N. Luebke, T. Feldt, V. Keitel, T. Brandenburger, D. Kindgen-Milles, M. Lutterbeck, N. Freise, D. Schoeler, R. Haas, A. Dilthey, A. Walker, J. Timm and T. Luedde, "Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany", The Lancet regional health. Europe, vol. 8, pp. 100164, 2021.
DOI:10.1016/j.lanepe.2021.100164
B. Jensen, N. Luebke, T. Feldt, V. Keitel, T. Brandenburger, D. Kindgen-Milles, M. Lutterbeck, N. F. Freise, D. Schoeler, R. Haas, A. Dilthey, O. Adams, A. Walker, J. Timm and T. Luedde, "Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany", The Lancet Regional Health- Europe, 2021.
DOI:10.1016/j.lanepe.2021.100164
Datei:https://doi.org/10.1016/j.lanepe.2021.100164
B. Jensen, N. Luebke, T. Feldt and et al, "Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany", Lancet Reg Health Eur, vol. 8, 2021.
DOI:10.1016/j.lanepe.2021.100164
L. Ruhl and et al, "Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks", Signal transduction and targeted therapy, vol. 6, pp. 418, 2021.
DOI:10.1038/s41392-021-00819-6
[German] S. Stillfried, P. Boor and D. PANDEMIcs, "Entwicklung eines kooperativen Obduktionsnetzwerks aus Pathologie, Neuropathologie und Rechtsmedizin", Pathologe, pp. 1-5, 2021.
DOI:10.1007/s00292-021-01004-w
[de] S. Stillfried, P. Boor and D. PANDEMIcs, "Entwicklung eines kooperativen Obduktionsnetzwerks aus Pathologie, Neuropathologie und Rechtsmedizin", Der Pathologe, vol. 42, no. 2, pp. 129—134, Dez. 2021.
DOI:10.1007/s00292-021-01004-w
Datei:https://doi.org/10.1007/s00292-021-01004-w
[German] F. Zack, S. Nigbur, H. Derani, D. Boy, A. Port and A. Büttner, "Erste Ergebnisse der Obduktionen der im Zusammenhang mit den SARS-CoV-2-Infektionen Verstorbenen aus der Unimedizin Rostock", Ärzteblatt Mecklenburg-Vorpommern, vol. 31, pp. 125—128, 2021.
Datei:pdfhttps://aerzteblatt-mvp.de/pdf/mv2104_125.pdf
F. Zack, S. Nigbur, J. Manhart, H. Derani, D. Boy, V. Kolbe and A. Büttner, "Erste Ergebnisse der Obduktionen der im Zusammenhang mit den SARS-CoV-2-Infektionen Verstorbenen aus der Unimedizin Rostock", Ärztebl Meckl-Vorpom, vol. 31, pp. 125-128, 2021.
A. Revet, J. Hebebrand, L. Kehoe, C. Child, S. Bender and P. Klauser, "ESCAP CovCAP survey of heads of academic departments to assess the perceived initial (April/May 2020) impact of the COVID-19 pandemic on child and adolescent psychiatry services", European Child & Adolescent Psychiatry, 2021.
DOI:10.1007/s00787-020-01699-x
R. Wagner, D. Peterhoff, S. Beileke and et al, "Estimates and determinants of SARS-Cov-2 seroprevalence and infection fatality ratio using latent class analysis: The population-based Tirschenreuth study in the hardest-hit German county in spring 2020", Viruses, vol. 13, no. 6, 2021.
DOI:10.3390/v13061118
Datei:https://doi.org/10.3390/v13061118
T. C. Jones and et al, "Estimating infectiousness throughout SARS-CoV-2 infection course", Science (New York, N.Y.), 2021.
DOI:10.1126/science.abi5273
[en] D. Nörz, M. Grunwald, F. Olearo, N. Fischer, M. Aepfelbacher, S. Pfefferle and M. Lütgehetmann, "Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with built-in screening functionality for del-HV69/70- and N501Y variants such as B.1.1.7", Journal of Clinical Virology, vol. 141, pp. 104894, Aug. 2021.
DOI:10.1016/j.jcv.2021.104894
Datei:https://www.sciencedirect.com/science/article/pii/S138665322100161X

Abstract:
.
K. A. Eberhardt and et al, "Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG", Microorganisms, vol. 9, 2021.
DOI:10.3390/microorganisms9040733
M. Korenkov, N. Poopalasingam, M. Madler and et al, "Evaluation of a Rapid Antigen Test To Detect SARS-CoV-2 Infection and Identify Potentially Infectious Individuals", J Clin Microbiol, vol. 59, no. 9, 2021.
DOI:10.1128/JCM.00896-21
T. Toptana, L. Eckermann, A. E. Pfeiffer and et al, "Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?", J Clin Virol, vol. 135, 2021.
DOI:10.1016/j.jcv.2020.104713
M. Metzendorf and R. M. Featherstone, "Evaluation of the comprehensiveness, accuracy and currency of the Cochrane COVID-19 Study Register for supporting rapid evidence synthesis production", Res Synth Methods, Jun. 2021.
DOI:10.1002/jrsm.1501
J. Hildebrandt, M. I. Metzendorf and T. Jakob, "Evaluierung der deutschen Datenbank Current Contents Medizin (CC MED) als potenzielle Datenquelle für das Cochrane COVID-19-Studienregister", GMS Med Inform Biom Epidemiol, vol. 17, no. 3, pp. Doc12, 2021.
DOI:10.3205/mibe000226
Datei:
[en] J. M. Kruse, D. Zickler, W. M. Lüdemann, S. K. Piper, I. Gotthardt, J. Ihlow, S. Greuel, D. Horst, A. Kahl, K. Eckardt and S. Elezkurtaj, "Evidence for a thromboembolic pathogenesis of lung cavitations in severely ill COVID-19 patients", Scientific Reports, vol. 11, no. 1, pp. 16039, Aug. 2021.
DOI:10.1038/s41598-021-95694-0
Datei:https://www.nature.com/articles/s41598-021-95694-0
M. Popp, P. Kranke, P. Meybohm, M. Metzendorf, N. Skoetz, M. S. Stegemann and S. Weibel, "Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges", BMJ Evid Based Med, vol. 2021, pp. bmjebm-2021-111791, 2021.
DOI:10.1136/bmjebm-2021-111791
J. Wachinger, M. Schirmer, N. Täuber and et al, "Experiences with opt-in, at-home screening for SARS-CoV-2 at a primary school in Germany: an implementation study", BMJ Paediatr Open, vol. 5, no. 1, 2021.
DOI:10.1136/bmjpo-2021-001262
Datei:https://doi.org/10.1136/bmjpo-2021-001262
J. M. Tielker, J. Weber, S. T. Simon, C. Bausewein, S. Stiel and N. Schneider, "Experiences, challenges and perspectives for ensuring end-of-life patient care: A national online survey with general practitioners in Germany", PLoS ONE, vol. 16, no. 7, pp. e0254056, 2021.
DOI:10.1371/journal.pone.0254056
K. Subbarayan, K. Ulagappan, C. Wickenhauser and B. Seliger, "Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues", Current Cancer Drug Targets, vol. 21, no. 5, pp. 428—442, Jul. 2021.
DOI:10.2174/1568009620666201207145019
Datei:https://www.eurekaselect.com/article/112117
[en] T. Hansen, U. Titze, N. S. A. Kulamadayil-Heidenreich, S. Glombitza, J. J. Tebbe, C. Röcken, B. Schulz, M. Weise and L. Wilkens, "First case of postmortem study in a patient vaccinated against SARS-CoV-2", International Journal of Infectious Diseases, vol. 107, pp. 172—175, Jun. 2021.
DOI:10.1016/j.ijid.2021.04.053
Datei:https://www.sciencedirect.com/science/article/pii/S1201971221003647
[Deutsch] P. Michel, G. Savinsky, B. Ondruschka and I. Czinczoll, "Folgen einer Reanimation in Zeiten der Pandemie", Hamburger Ärzteblatt, vol. 2021, no. 11, pp. 28—30, 2021.
Datei:https://fis-uke.de/portal/de/publications/folgen-einer-reanimation-in-zeiten-der-pandemie(943a98ca-7e65-4bc3-abeb-f520157640a7).html
M. Muenchhoff, A. Graf, S. Krebs and et al, "Genomic epidemiology reveals multiple introductions of SARS-CoV-2 followed by community and nosocomial spread, Germany, February to May 2020", Euro Surveill, vol. 26, no. 43, 2021.
DOI:10.2807/1560-7917.ES.2021.26.43.2002066
Datei:https://doi.org/10.2807/1560-7917.ES.2021.26.43.2002066
S. Thun, J. Sass and A. Bartschke, "German Corona Consensus Datensatz (GECCO): Verbesserter Austausch von COVID-19-Forschungsdaten", kma - Klinik Management aktuell, vol. 26, no. 06, pp. 55—56, 2021.
DOI:10.1055/s-0041-1731187
A. Gruber, T. Firsching, J. Trimpert and K. Dietert, "Hamster models of COVID-19 pneumonia reviewed: How human can they be?", Vet Pathol, 2021.
[en] F. Olearo, D. Nörz, F. Heinrich, J. P. Sutter, K. Roedl, A. Schultze, J. Wiesch, P. Braun, L. Oestereich, B. Kreuels, D. Wichmann, M. Aepfelbacher, S. Pfefferle and M. Lütgehetmann, "Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR", Journal of Clinical Virology, vol. 137, pp. 104782, Apr. 2021.
DOI:10.1016/j.jcv.2021.104782
Datei:https://www.sciencedirect.com/science/article/pii/S1386653221000494
M. Schmidt, S. Kugai and B. Weltermann, "Handlungsfähigkeit von Hausärzt*innen während der COVID-19-Pandemie", DocV-15-05, 2021.
DOI:10.3205/21degam086
J. A. F. Klein, L. J. Krüger, F. Tobian and et al, "Head-to-head performance comparison of self-collected nasal versus professional-collected nasopharyngeal swab for a WHO-listed SARS-CoV-2 antigen-detecting rapid diagnostic test", Med Microbiol Immunol, vol. 210, no. 4, 2021.
DOI:10.1007/s00430-021-00710-9
Datei:https://doi.org/10.1007/s00430-021-00710-9
S. Hadzibegovic, A. Lena, T. Churchill, J. Ho, S. Potthoff, C. Denecke, L. Rösnick, K. Heim, M. Kleinschmidt, L. Sander and D. Stahl, "Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings", Eur J Heart Fail, vol. 23, no. 11, pp. 1891—1902, 2021.
DOI:10.1002/ejhf.2210
[en] B. Kaltschmidt, A. D. E. Fitzek, J. Schaedler, C. Förster, C. Kaltschmidt, T. Hansen, F. Steinfurth, B. A. Windmöller, C. Pilger, C. Kong, K. Singh, A. Nierhaus, D. Wichmann, J. Sperhake, K. Püschel, T. Huser, M. Krüger, S. C. Robson, L. Wilkens and J. Esch, "Hepatic Vasculopathy and Regenerative Responses of the Liver in Fatal Cases of COVID-19", Clinical Gastroenterology and Hepatology, vol. 19, no. 8, pp. 1726—1729.e3, Aug. 2021.
DOI:10.1016/j.cgh.2021.01.044
Datei:https://www.sciencedirect.com/science/article/pii/S154235652100094X
R. Groß and et al, "Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants", EBioMedicine, vol. 75, pp. 103761, 2021.
DOI:10.1016/j.ebiom.2021.103761
M. Tenbusch, S. Schumacher, E. Vogel and et al, "Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2", Lancet Infect Dis, vol. 21, no. 9, 2021.
DOI:10.1016/S1473-3099(21)00420-5
M. Rössler, J. Jacob, L. Risch, F. Tesch, D. Enders, D. Wende, R. Jucknewitz, O. Weidinger, M. Batram, P. Ballesteros, S. Baßler, D. Hertle, U. Repschläger, N. Richter, C. Schulte, A. Schramm, F. Sobik, M. Treskova-Schwarzbach, S. Scholz, J. Walker and D. Stahl, "Hierarchisierung von Risikofaktoren für schwere COVID-19-Erkrankungsverläufe im Kontext der COVID-19-Schutzimpfungen", 2021.
DOI:10.25646/8405.2
M. Lehmann, C. Heldt, J. Meinhardt, F. Schmidt and e. a. Rodriguez-Sillke, "Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8(+) T cells", Mucosal Immunol, vol. 14, pp. 1381—1392, 2021.